Prognostic factors in FIGO stage IB cervical cancer without lymph node metastasis and the role of adjuvant radiotherapy after radical hysterectomy

被引:60
作者
Ayhan, A
Al, RA
Baykal, C
Demirtas, E
Ayhan, A
Yüce, K
机构
[1] Hacettepe Univ Hosp, Dept Obstet & Gynecol, Ankara, Turkey
[2] Hacettepe Univ Hosp, Dept Pathol, Ankara, Turkey
关键词
cervical cancer; lymphatic metastasis; radiotherapy; survival;
D O I
10.1111/j.1048-891X.2004.014212.x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objectives: The aim of this study was to evaluate the clinical and pathologic prognostic variables for disease free survival, overall survival and the role of adjuvant radiotherapy in FIGO stage IB cervical carcinoma without lymph node metastasis. Methods: A retrospective review was performed of 393 patients with lymph node negative stage IB cervical cancer treated by type 3 hysterectomy and pelvic lymphadenectomy at the Hacettepe University Hospitals between 1980 and 1997. Results: The disease free survival and overall survival were 87.6 and 91.0%, respectively. In univariate analysis, tumor size, depth of invasion, vaginal involvement, lympho-vascular space involvement (LVSI) and adjuvant radiotherapy were found significant in disease free survival. Overall survival was affected by tumor size, LVSI, vaginal involvement and adjuvant radiotherapy. Tumor size, LVSI and vaginal involvement were found as independent prognostic factors for overall and disease free survival in multivariate analysis. Disease free survival, recurrence rate and site did not differ between patients underwent radical surgery and radical surgery plus radiotherapy. Conclusion: Tumor size, LVSI and vaginal involvement were independent prognostic factors in lymph node negative FIGO stage IB cervical cancer. Adjuvant radiotherapy in stage IB cervical cancer patients with negative nodes provides no survival advantage or better local tumoral control.
引用
收藏
页码:286 / 292
页数:7
相关论文
共 38 条
[1]   Stage IA carcinoma of the cervix revisited [J].
Benedet, JL ;
Anderson, GH .
OBSTETRICS AND GYNECOLOGY, 1996, 87 (06) :1052-1059
[2]   Lymph node metastases and prognosis in patients with stage IA(2) cervical cancer [J].
Buckley, SL ;
Tritz, DM ;
VanLe, L ;
Higgins, R ;
Sevin, BU ;
Ueland, FR ;
DePriest, PD ;
Gallion, HH ;
Bailey, CL ;
Kryscio, RJ ;
Fowler, W ;
Averette, H ;
Vannagell, JR .
GYNECOLOGIC ONCOLOGY, 1996, 63 (01) :4-9
[3]   PROGNOSTIC FACTORS ASSOCIATED WITH RADICAL HYSTERECTOMY FAILURE [J].
BURKE, TW ;
HOSKINS, WJ ;
HELLER, PB ;
BIBRO, MC ;
WEISER, EB ;
PARK, RC .
GYNECOLOGIC ONCOLOGY, 1987, 26 (02) :153-159
[4]   Adjuvant chemotherapy versus chemotherapy plus pelvic irradiation for high-risk cervical cancer patients after radical hysterectomy and pelvic lymphadenectomy (RH-PLND): A randomized phase III trial [J].
Curtin, JP ;
Hoskins, WJ ;
Venkatraman, ES ;
Almadrones, L ;
Podratz, KC ;
Long, H ;
Teneriello, M ;
Averette, H ;
Sevin, BU .
GYNECOLOGIC ONCOLOGY, 1996, 61 (01) :3-10
[5]   PROSPECTIVE SURGICAL PATHOLOGICAL-STUDY OF DISEASE-FREE INTERVAL IN PATIENTS WITH STAGE IB SQUAMOUS-CELL CARCINOMA OF THE CERVIX - A GYNECOLOGIC ONCOLOGY GROUP-STUDY [J].
DELGADO, G ;
BUNDY, B ;
ZAINO, R ;
SEVIN, BU ;
CREASMAN, WT ;
MAJOR, F .
GYNECOLOGIC ONCOLOGY, 1990, 38 (03) :352-357
[6]   DETERMINANTS OF INCREASED RISK FOR RECURRENCE IN PATIENTS UNDERGOING RADICAL HYSTERECTOMY FOR STAGE-IB AND STAGE-IIA CARCINOMA OF THE CERVIX [J].
FULLER, AF ;
ELLIOTT, N ;
KOSLOFF, C ;
HOSKINS, WJ ;
LEWIS, JL .
GYNECOLOGIC ONCOLOGY, 1989, 33 (01) :34-39
[7]  
INOUE T, 1990, CANCER, V65, P1923, DOI 10.1002/1097-0142(19900501)65:9<1923::AID-CNCR2820650909>3.0.CO
[8]  
2-M
[9]   Prognostic factors of adenocarcinoma of the uterine cervix [J].
Ishikawa, H ;
Nakanishi, T ;
Inoue, T ;
Kuzuya, K .
GYNECOLOGIC ONCOLOGY, 1999, 73 (01) :42-46
[10]   VALUE OF ADJUVANT WHOLE-PELVIS IRRADIATION AFTER WERTHEIM HYSTERECTOMY FOR EARLY-STAGE SQUAMOUS CARCINOMA OF THE CERVIX WITH PELVIC NODAL METASTASIS - A MATCHED-CONTROL STUDY [J].
KINNEY, WK ;
ALVAREZ, RD ;
REID, GC ;
SCHRAY, MF ;
SOONG, SJ ;
MORLEY, GW ;
PODRATZ, KC ;
SHINGLETON, HM .
GYNECOLOGIC ONCOLOGY, 1989, 34 (03) :258-262